{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T23:19:59Z","timestamp":1794093599589,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T00:00:00Z","timestamp":1706918400000},"content-version":"am","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["T32 ES007060\u201331A1"],"award-info":[{"award-number":["T32 ES007060\u201331A1"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["D34HP31025"],"award-info":[{"award-number":["D34HP31025"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.forsciint.2023.111579","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T21:27:15Z","timestamp":1675114035000},"page":"111579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Examination of methadone involved overdoses during the COVID-19 pandemic"],"prefix":"10.1016","volume":"344","author":[{"given":"Daniel E.","family":"Kaufman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Kennalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"McCall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Piper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2023.111579_bib1","unstructured":"Mann B. More than a million Americans have died from overdoses during the opioid epidemic. NPR. Accessed 8\/21\/22 at: \u3008https:\/\/www.npr.org\/2021\/12\/30\/1069062738\/more-than-a-million-americans-have-died-from-overdoses-during-the-opioid-epidemi\u3009."},{"key":"10.1016\/j.forsciint.2023.111579_bib2","unstructured":"SAMSA. Methadone. Accessed 4\/1\/22: \u3008https:\/\/www.samhsa.gov\/medication-assisted-treatment\/medications-counseling-related-conditions\/methadone\u3009."},{"issue":"5","key":"10.1016\/j.forsciint.2023.111579_bib3","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.amepre.2018.01.034","article-title":"Trends in medical use of opioids in the U.S., 2006-2016","volume":"54","author":"Piper","year":"2018","journal-title":"Am. J. Prev. Med"},{"issue":"3","key":"10.1016\/j.forsciint.2023.111579_bib4","first-page":"271","article-title":"Pronounced regional disparities in United States methadone distribution","volume":"56","author":"Furst","year":"2022","journal-title":"Ann. Pharm."},{"key":"10.1016\/j.forsciint.2023.111579_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drugalcdep.2017.11.023","article-title":"A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: findings at 12 months post-release","volume":"184","author":"Brinkley-Rubinstein","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forsciint.2023.111579_bib6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/add.13238","article-title":"Long-term outcomes after randomization to buprenorphine\/naloxone versus methadone in a multi-site trial","volume":"111","author":"Hser","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.forsciint.2023.111579_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub3","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.forsciint.2023.111579_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109575","article-title":"Sex differences in weight gain during medication-based treatment for opioid use disorder: a meta-analysis and retrospective analysis of clinical trial data","volume":"238","author":"Manza","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forsciint.2023.111579_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108449","article-title":"Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19","volume":"131","author":"Brothers","year":"2021","journal-title":"J. Subst. Abus. Treat."},{"issue":"26","key":"10.1016\/j.forsciint.2023.111579_bib10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.15585\/mmwr.mm6526a2","article-title":"Trends in methadone distribution for pain: treatment, methadone diversion, and overdose deaths - United States, 2002\u20132014","volume":"65","author":"Jones","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.forsciint.2023.111579_bib11","doi-asserted-by":"crossref","first-page":"131Y135","DOI":"10.1097\/PAF.0b013e3181e8af3d","article-title":"The methadone epidemic: Methadone-related deaths on the rise in Vermont","volume":"32","author":"Madden","year":"2011","journal-title":"Am. J. Forensic Med. Pathol."},{"issue":"8","key":"10.1016\/j.forsciint.2023.111579_bib12","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.2810","article-title":"Crowdsourcing black market prices for prescription opioids","volume":"15","author":"Dasgupta","year":"2013","journal-title":"J. Med Internet Res."},{"issue":"14","key":"10.1016\/j.forsciint.2023.111579_bib13","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence","volume":"41","author":"Eap","year":"2002","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.forsciint.2023.111579_bib14","series-title":"FAQs: Provision of methadone and buprenorphine for the treatment of opioid use disorder in the COVID-19 emergency","author":"SAMHSA","year":"2020"},{"key":"10.1016\/j.forsciint.2023.111579_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108655","article-title":"\u201cNo home to take methadone to\u201d: experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston","volume":"135","author":"Harris","year":"2022","journal-title":"J. Subst. Abus Treat."},{"key":"10.1016\/j.forsciint.2023.111579_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12954-021-00535-y","article-title":"It\u2019s like \u2018liquid handcuffs\u201d: the effects of take\u2011home dosing policies on methadone maintenance treatment (MMT) patients\u2019 lives","volume":"18","author":"Frank","year":"2021","journal-title":"Harm Reduct. J."},{"issue":"1","key":"10.1016\/j.forsciint.2023.111579_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13722-021-00281-3","article-title":"Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis","volume":"16","author":"Levander","year":"2021","journal-title":"Addict. Sci. Clin. Pr."},{"key":"10.1016\/j.forsciint.2023.111579_bib18","doi-asserted-by":"crossref","first-page":"c4851","DOI":"10.1136\/bmj.c4851","article-title":"Impact of supervision of methadone consumption on deaths related to methadone overdose (1993-2008): analyses using OD4 index in England and Scotland","volume":"341","author":"Strang","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.forsciint.2023.111579_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103591","article-title":"Methadone exposures reported to poison control centers in the United States following the COVID-19-related loosening of federal methadone regulations","volume":"102","author":"Welsh","year":"2022","journal-title":"Int J. Drug Policy"},{"key":"10.1016\/j.forsciint.2023.111579_bib20","unstructured":"Centers for Disease Control and Prevention. Wide-ranging Online Data for Epidemiologic Research (WONDER) database. Accessed 22 August 2022 at: \u3008https:\/\/wonder.cdc.gov\/\u3009."},{"key":"10.1016\/j.forsciint.2023.111579_bib21","article-title":"Methadone-involved overdose deaths in the United States before and during the COVID-19 pandemic","volume":"242","author":"Kleimann","year":"2023","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.forsciint.2023.111579_sbref19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/a-1353-6509","article-title":"Opioid mortality following implementation of medical cannabis programs in the United States","volume":"54","author":"Kaufman","year":"2021","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"10.1016\/j.forsciint.2023.111579_sbref20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/pds.980","article-title":"An analysis of the significant variation in psychostimulant use across the U.S","volume":"14","author":"Bokhari","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"5","key":"10.1016\/j.forsciint.2023.111579_bib23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.amepre.2018.01.034","article-title":"Trends in medical use of opioids in the U.S., 2006-2016","volume":"54","author":"Piper","year":"2018","journal-title":"Am. J. Prev. Med"},{"key":"10.1016\/j.forsciint.2023.111579_bib24","unstructured":"IQVIA. The use of medicines in the US: Spending and usage trend and outlook to 2025. Accessed 5\/2\/2022 at: \u3008https:\/\/www.iqvia.com\/insights\/the-iqvia-institute\/reports\/the-use-of-medicines-in-the-us#:\u223c:text=Total%20net%20spending%20on%20medicines,off%2Dinvoice%20discounts%20and%20rebates\u3009."},{"issue":"12","key":"10.1016\/j.forsciint.2023.111579_bib25","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"Strobe initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","author":"Von Elm","year":"2014","journal-title":"Int J. Surg."},{"key":"10.1016\/j.forsciint.2023.111579_bib26","article-title":"Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms","volume":"132","author":"Treitler","year":"2022","journal-title":"Subst. Abus. Treat."},{"key":"10.1016\/j.forsciint.2023.111579_bib27","unstructured":"Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS): 2020. Data on Substance Abuse Treatment Facilities. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2021."},{"issue":"2","key":"10.1016\/j.forsciint.2023.111579_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/PAF.0b013e3181e8af3d","article-title":"The methadone epidemic: methadone-related deaths on the rise in Vermont","volume":"32","author":"Madden","year":"2011","journal-title":"Am. J. Forensic Med. Pathol."},{"issue":"12","key":"10.1016\/j.forsciint.2023.111579_bib29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.15585\/mmwr.mm6612a2","article-title":"Methadone prescribing and overdose and the association with Medicaid preferred drug list policies - United States, 2007\u20132014","volume":"66","author":"Faul","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.forsciint.2023.111579_bib30","series-title":"Public health advisory: methadone use for pain control may result in death and life-threatening changes in breathing and heartbeat","author":"Food and Drug Administration","year":"2006"},{"issue":"Suppl 2","key":"10.1016\/j.forsciint.2023.111579_bib31","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1111\/j.1526-4637.2011.01134.x","article-title":"An analysis of the root causes for opioid-related overdose deaths in the United States","volume":"12","author":"Webster","year":"2011","journal-title":"Pain. Med"},{"key":"10.1016\/j.forsciint.2023.111579_bib32","article-title":"Comment on: an analysis of the root causes for opioid-related overdose deaths in the United States","author":"Fusca","year":"2011","journal-title":"Pain. Med."},{"key":"10.1016\/j.forsciint.2023.111579_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2022.1776","article-title":"Methadone-involved overdose deaths in the US before and after federal policy changes expanding take-home methadone doses from opioid treatment programs","author":"Jones","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.forsciint.2023.111579_othref0030","doi-asserted-by":"crossref","unstructured":"Kennalley A.L., Fanelli J.L., Furst J.A., Mynarski N.J., Nichols S.D., Piper B.J. Reversal of increases in methadone distribution for opioid use disorder in the US during the COVID-19 pandemic. MedRxIv, \u3008https:\/\/doi.org\/10.1101\/2022.03.09.22272154\u3009.","DOI":"10.1101\/2022.03.09.22272154"},{"key":"10.1016\/j.forsciint.2023.111579_othref0035","doi-asserted-by":"crossref","unstructured":"Friedman J., Montero F., Bourgois P., Wahbi R., Dye D., Goodman-Meza D., Shover C. Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis. Drug Alcohol Depend. 2022;233:109380. doi: 10.1016\/j.drugalcdep.2022.109380.","DOI":"10.1016\/j.drugalcdep.2022.109380"},{"key":"10.1016\/j.forsciint.2023.111579_bib35","first-page":"bkac023","article-title":"Reports of adverse events associated with use of novel psychoactive substances, 2017-2020: a review","author":"Mohr","year":"2022","journal-title":"J. Anal. Toxicol."},{"issue":"9","key":"10.1016\/j.forsciint.2023.111579_bib36","article-title":"What your death certificate says about you may be wrong: a narrative review on CDC's efforts to quantify prescription opioid overdose deaths","volume":"13","author":"Peppin","year":"2021","journal-title":"Cureus"}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073823000294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073823000294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T18:10:48Z","timestamp":1759947048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073823000294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":38,"alternative-id":["S0379073823000294"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2023.111579","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examination of methadone involved overdoses during the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2023.111579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111579"}}